These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26911803)

  • 21. [Artemisinin resistance in Plasmodium falciparum: global status and basic research].
    Zhao SM; Wang MY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Oct; 32(5):380-4. PubMed ID: 25726605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Past and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventions.
    Guyant P; Corbel V; Guérin PJ; Lautissier A; Nosten F; Boyer S; Coosemans M; Dondorp AM; Sinou V; Yeung S; White N
    Malar J; 2015 Jul; 14():279. PubMed ID: 26185098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
    Djimde AA; Makanga M; Kuhen K; Hamed K
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):1031-45. PubMed ID: 26081265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
    van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
    Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vector control to eliminate artemisinin resistant malaria in the Greater Mekong subregion.
    Kolaczinski J; Macdonald M; Meek S
    Lancet Infect Dis; 2014 Jan; 14(1):9-11. PubMed ID: 24355026
    [No Abstract]   [Full Text] [Related]  

  • 26. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
    Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
    Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and prospects for malaria elimination in the Greater Mekong Subregion.
    Cui L; Yan G; Sattabongkot J; Chen B; Cao Y; Fan Q; Parker D; Sirichaisinthop J; Su XZ; Yang H; Yang Z; Wang B; Zhou G
    Acta Trop; 2012 Mar; 121(3):240-5. PubMed ID: 21515238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated CDC Recommendations for Using Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in Pregnant Women in the United States.
    Ballard SB; Salinger A; ; Arguin PM; Desai M; Tan KR
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(14):424-431. PubMed ID: 29649190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keeping the momentum: suggestions for treatment policy updates in the final push to eliminate malaria in India.
    Valecha N
    Malar J; 2023 Apr; 22(1):128. PubMed ID: 37072795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria: an update for physicians.
    Nadjm B; Behrens RH
    Infect Dis Clin North Am; 2012 Jun; 26(2):243-59. PubMed ID: 22632637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy--a way to forestall artemisinin resistance and optimize uncomplicated malaria treatment.
    Ștefan I
    J Med Life; 2015; 8(3):326-8. PubMed ID: 26351534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Introduction of World Health Organization Strategies and the Technical Advisory Committee actions on viral hepatitis control and status of the elimination of viral hepatitis in China].
    Cui FQ; Wang FZ; Zheng H; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1523-1526. PubMed ID: 34814578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance screening and trend analysis of imported falciparum malaria in NSW, Australia (2010 to 2016).
    Prosser C; Meyer W; Ellis J; Lee R
    PLoS One; 2018; 13(5):e0197369. PubMed ID: 29813085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
    Ogbonna A; Uneke CJ
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):621-7. PubMed ID: 18499204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-resistant malaria advances in Mekong.
    Roberts L
    Science; 2017 Oct; 358(6360):155-156. PubMed ID: 29026020
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.